Data / Form D filings / Sensible Biotechnologies, Inc.
Sensible Biotechnologies, Inc.: Form D filings
Sensible Biotechnologies, Inc., a biotechnology company in Oxford, Oxfordshire, United Kingdom, filed 2 Form D notices with the SEC between 2023 and 2026. The latest, on September 2, 2026, reports $13.5 million sold of a $15 million offering to 15 investors.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- Osford Brookes Enterprise Hub Headington Road, Oxford, Oxfordshire, United Kingdom, OX3 0
- Phone
- 44 7599 496 330
- Industry
- Biotechnology
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2021
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1964363
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | New notice | $15,000,000 | $13,518,941 | $1,481,059 | 15 | Aug 17, 2026 | sec.gov |
| Feb 21, 2023 | New notice | $3,000,000 | $1,829,000 | $1,171,000 | 18 | Feb 6, 2023 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Miroslav Gasparek | Executive Officer, Director | |
| Marian Kupculak | Executive Officer, Director | |
| Joel Schoppig | Director | |
| Vishal Gulati | Director |
Every Form D from the week of Aug 31, 2026 · All recent Biotechnology filings
Read from SEC EDGAR. Amount sold is what Sensible Biotechnologies, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.